Anticancer agent 112

Anticancer agent 112 is a potent anti-cancer agent for cancer research, extracted from patent WO2020198567[1].

Product Specifications

CAS Number

[2495321-37-2]

UNSPSC

12352005

Target

Others

Type

Reference compound

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/anticancer-agent-112.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CC(C2=NC(C)=C(NCCNC)C=C2)=NC3=CC=C(Cl)C=C13)N(CC4=CN=C(CC)N4C)C

Molecular Formula

C27H32ClN7O

Molecular Weight

506.04

References & Citations

[1]Eamon Comer, et al. Quinoline derivatives and their use for the treatment of cancer. Patent WO2020198567

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

NBP3-14004IR 0.1 mL

Rabbit Monoclonal MUC5AC Antibody (MUC5AC/7067R) [DyLight 755]

Ask

View Details

K0201-01C 10 µg

Keratinocyte Growth Factor, Recombinant, Human (KGF, Fibroblast Growth Factor 7, FGF-7) (Human 293 Cells) discontinued

Ask

View Details

NBP2-73311FR 0.1 mL

Mouse Monoclonal PDLIM2 Antibody (OTI11A12) [DyLight 680]

Ask

View Details

HY-RS03039 1 Set

COQ3 Human Pre-designed siRNA Set A

Ask

View Details

TA502812BM 100 µL

PPM1B Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI3C2]

Ask

View Details

GWB-E9F8C0 0.1 mg

Rgs1 Antibody

Ask

View Details